GnRH agonist therapy before myomectomy or hysterectomy
Authors:
- Jacqueline N. GutmannJGJacqueline N. Gutmann
- Stephen L. CorsonSCStephen L. Corson
- 1 December 2005
- journal article
- review article
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 12 (6) , 529-537
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomataFertility and Sterility, 2002
- Genotype distribution of estrogen receptor-α gene polymorphisms in italian women with surgical uterine leiomyomasFertility and Sterility, 2001
- Uterine fibroidsThe Lancet, 2001
- Progesterone: A critical role in the pathogenesis of uterine myomasAmerican Journal of Obstetrics and Gynecology, 1995
- Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 womenFertility and Sterility, 1990
- The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypooestrogenic by continuous administration of an LHRH agonistBJOG: An International Journal of Obstetrics & Gynaecology, 1988
- Long-acting gonadotropin hormone-releasing hormone analogused to treat uteriFertility and Sterility, 1986
- Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot studyAmerican Journal of Obstetrics and Gynecology, 1985
- Aromatase activity in uterine leiomyomataThe Journal of Steroid Biochemistry and Molecular Biology, 1984
- A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogueAmerican Journal of Obstetrics and Gynecology, 1983